semaglutide push health GLP-1 drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. . As research uncovers potential benefits beyond weight loss, experts are Semaglutide Journey Through Push Health

Whether they are natural or synthetic, their chemical structures are identical

Comprehensive Modalities for Cataract Management: Preventive, Surgical, and Non-Surgical Approaches Using Conventional and Nanotechnology-Based Therapies

Odegard PS, Setter SM, Neumiller JJ

Lyme disease

Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.